Home › Companies › ATEA PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ATEA PHARMACEUTICALS INC.’s Form 8-K, filed 2024-06-21 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore ATEA PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ATEA PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-21 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Franklin Berger | 30,459,345 | -- | -- | -- | 15,563,551 | — |
| Elect Director: Jean-Pierre Sommadossi, Ph.D. | 40,751,581 | -- | -- | -- | 15,563,551 | — |
| Item 2 — Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. | 62,300,216 | 6,472,069 | 5,593,194 | -- | 0 | Majority: yes |
| Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. | 42,900,395 | 15,499,499 | 402,034 | -- | 15,563,551 | Passed |
Source: ATEA PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-06-21 — read the filing on EDGAR.
Each item below shows how the 127 asset managers that disclosed a ATEA PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 11 wordings of this item as funds reported it.
73% Passed · of votes cast
ATEA PHARMACEUTICALS INC.’s own tally for this item (“Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.”): 42,900,395 for, 15,499,499 against — passed, per its Form 8-K filed 2024-06-21 (Item 5.07). Of all 84,223,100 outstanding shares: 50.9% for, 18% against (69% of the company cast a for/against vote).
The 127 asset managers below cast 80% of the shares they voted on this item FOR (36,296,714 for, 9,152,479 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,187,404 | 0 | 0 | 0 | For |
| BlackRock | 7,387,450 | 25,994 | 0 | 0 | For |
| EcoR1 Capital, LLC | 0 | 6,145,861 | 0 | 0 | Against |
| Vanguard | 4,723,266 | 0 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,906,463 | 0 | 0 | 0 | For |
| State Street | 1,605,243 | 1,925 | 0 | 0 | For |
| Charles Schwab | 0 | 1,228,016 | 0 | 0 | Against |
| Federated Hermes | 1,102,801 | 0 | 0 | 0 | For |
| Renaissance | 1,006,262 | 0 | 0 | 0 | For |
| Northern Trust | 620,877 | 103 | 0 | 0 | For |
| Two Sigma | 462,586 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 457,854 | 0 | 0 | 0 | For |
| Dimensional | 0 | 406,401 | 0 | 0 | Against |
| Newtyn Management, LLC | 400,000 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 370,937 | 0 | 0 | 0 | For |
| Wellington | 0 | 313,700 | 0 | 0 | Against |
| Nuveen | 291,091 | 0 | 0 | 0 | For |
| TIAA | 289,493 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 268,328 | 0 | 0 | 0 | For |
| Equitable | 252,288 | 0 | 0 | 0 | For |
| Citadel | 245,662 | 0 | 0 | 0 | For |
| Allianz | 0 | 226,574 | 0 | 0 | Against |
| American Century | 0 | 223,670 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 200,628 | 0 | 0 | 0 | For |
Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 42 asset managers below cast 100% of the shares they voted on this item FOR (10,499,621 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,653,782 | 0 | 0 | 0 | For |
| Fidelity | 4,203,719 | 0 | 111,837 | 0 | For |
| BlackRock | 0 | 0 | 4,167,442 | 0 | Abstain |
| Charles Schwab | 614,008 | 0 | 0 | 0 | For |
| Federated Hermes | 549,380 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 323,733 | 0 | Abstain |
| TIAA | 289,493 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 252,288 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 146,690 | 0 | Abstain |
| American Century | 0 | 0 | 111,835 | 0 | Abstain |
| Nationwide | 0 | 0 | 109,933 | 0 | Abstain |
| Columbia Threadneedle | 105,243 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 70,000 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 67,325 | 0 | Abstain |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 59,077 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 58,907 | 0 | Abstain |
| T. Rowe Price | 49,020 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 37,779 | 0 | Abstain |
| GuideStone | 0 | 0 | 36,540 | 0 | Abstain |
| Bridge Builder Trust | 0 | 0 | 31,709 | 0 | Abstain |
| Pacific Life | 0 | 0 | 30,628 | 0 | Abstain |
| John Hancock | 0 | 0 | 30,359 | 0 | Abstain |
| Voya | 0 | 0 | 28,547 | 0 | Abstain |
| State Street | 0 | 0 | 24,839 | 0 | Abstain |
| ProShares | 0 | 0 | 20,795 | 0 | Abstain |
Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 42 asset managers below cast 100% of the shares they voted on this item FOR (15,398,044 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,653,782 | 0 | 0 | 0 | For |
| Fidelity | 4,314,456 | 0 | 1,100 | 0 | For |
| BlackRock | 4,167,442 | 0 | 0 | 0 | For |
| Charles Schwab | 614,008 | 0 | 0 | 0 | For |
| Federated Hermes | 549,380 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 323,733 | 0 | Abstain |
| TIAA | 289,493 | 0 | 0 | 0 | For |
| Equitable | 252,288 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 146,690 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 111,835 | 0 | Abstain |
| Nationwide | 0 | 0 | 109,933 | 0 | Abstain |
| Columbia Threadneedle | 105,243 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 70,000 | 0 | Abstain |
| Lincoln Financial | 63,300 | 0 | 4,025 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 59,077 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 0 | 0 | 58,907 | 0 | Abstain |
| T. Rowe Price | 49,020 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 37,779 | 0 | Abstain |
| GuideStone | 0 | 0 | 36,540 | 0 | Abstain |
| Bridge Builder Trust | 31,709 | 0 | 0 | 0 | For |
| Pacific Life | 30,628 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 30,359 | 0 | Abstain |
| Voya | 0 | 0 | 28,547 | 0 | Abstain |
| State Street | 24,839 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 20,795 | 0 | Abstain |
Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.
Combines 2 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
ATEA PHARMACEUTICALS INC.’s own tally for this item (“Item 2 — Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.”): 62,300,216 for, 6,472,069 against, per its Form 8-K filed 2024-06-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 84,223,100 outstanding shares: 74% for, 8% against (82% of the company cast a for/against vote).
The 42 asset managers below cast 100% of the shares they voted on this item FOR (16,294,147 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,653,782 | 0 | 0 | 0 | For |
| Fidelity | 4,315,556 | 0 | 0 | 0 | For |
| BlackRock | 4,167,442 | 0 | 0 | 0 | For |
| Charles Schwab | 614,008 | 0 | 0 | 0 | For |
| Federated Hermes | 549,380 | 0 | 0 | 0 | For |
| Dimensional | 323,733 | 0 | 0 | 0 | For |
| TIAA | 289,493 | 0 | 0 | 0 | For |
| Equitable | 252,288 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 146,690 | 0 | 0 | 0 | For |
| American Century | 111,835 | 0 | 0 | 0 | For |
| Nationwide | 109,933 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 105,243 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 70,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 67,325 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 59,077 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 58,907 | 0 | 0 | 0 | For |
| T. Rowe Price | 49,020 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 37,779 | 0 | 0 | 0 | For |
| GuideStone | 36,540 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 31,709 | 0 | 0 | 0 | For |
| Pacific Life | 30,628 | 0 | 0 | 0 | For |
| John Hancock | 30,359 | 0 | 0 | 0 | For |
| Voya | 28,547 | 0 | 0 | 0 | For |
| State Street | 24,839 | 0 | 0 | 0 | For |
| ProShares | 20,795 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.
Ranked by the number of ATEA PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 84,223,100 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 12.10% |
| 2 | BlackRock | 8.80% |
| 3 | EcoR1 Capital, LLC | 7.30% |
| 4 | Vanguard | 5.61% |
| 5 | Bain Capital Life Sciences Investors, LLC | 2.95% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.26% |
| 7 | State Street | 1.91% |
| 8 | Charles Schwab | 1.46% |
| 9 | Federated Hermes | 1.31% |
| 10 | Renaissance | 1.19% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 10.04% | 13F |
| FMR (Fidelity) | 6.91% | 13F |
| Vanguard Group | 5.59% | 13F |
| Geode Capital | 2.24% | 13F |
| State Street | 1.99% | 13F |
| Renaissance Technologies | 1.33% | 13F |
| Northern Trust | 0.82% | 13F |
| JPMorgan Chase | 0.73% | 13F |
| Charles Schwab | 0.73% | 13F |
| Morgan Stanley | 0.53% | 13F |
Percentages above are of 84,223,100 shares outstanding, as reported by ATEA PHARMACEUTICALS INC. on its Form 10-Q dated 2024-05-13 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ATEA PHARMACEUTICALS INC.’s 10-Q dated 2024-05-13. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At ATEA PHARMACEUTICALS INC.'s shareholder meeting held 2024-06-21, in the 2023-2024 proxy season, 127 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 688 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory (non- binding) basis, of the compensation of the named executive… — the proposal passed with 73% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ATEA PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-21.
ATEA PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.